Member Info for surprised

https://twitter.com/surprised_trade/status/1593213307191984130

Autumn statement today 'NHS budget to be increased by 3.3bilion pounds a year'...TLY will benefit accordingly

excellent presentation, Wendy & Lisa know their business, market should be confident in the potential growth and shareholder return....broker target 75p

https://twitter.com/surprised_trade/status/1593323852817481731

profits expected to be ahead of expectations & today's 'budget' very likely to increase profits further as pawnbroking business continues to grow. ..broker has 240p target

NHS budget to be increased by 3.3bilion pounds a year...TLY will benefit accordingly

wft is only on 'excess profits' not profits per se

wft as expected and still 91p return on uk investment, so SQZ still looking very
good ...

.
excellent results. Free cash flow, profits and increasing, what every investor looks for..somehow the sp has fallen back to current, broker target of 130p is clearly closer to where sp should be

https://twitter.com/surprised_trade/status/1593146289658552320

https://twitter.com/surprised_trade/status/1592943762493550593

excellent presentation, Wendy & Lisa know their business, market should be confident in the potential growth and shareholder return....broker target 75p

https://www.investormeetcompany.com/investor/meeting/interim-results-125

European natural gas prices are up 25% so far this week as the region braces for its first winter cold snap

The market is on edge as Europe enters winter without Russian gas supply

https://twitter.com/surprised_trade/status/1592454625244086272

https://twitter.com/surprised_trade/status/1592454625244086272

European natural gas prices are up 25% so far this week as the region braces for its first winter cold snap

The market is on edge as Europe enters winter without Russian gas supply

new broker note ...

Today’s news is another positive step forward for CAP-XX as these orders are for a high value product, that is completely new in the CAP-XX product portfolio, and is being sold into a new market with significant potential.

We estimate these large water-cooled modules are likely to be priced in the low hundreds of thousands of US$ per ship, and that the market opportunity is more than 50,000 large cargo ships.
Whilst MARINE EDGE looks to be a relatively young Israeli company, we believe it is well funded and with a competitive product that significantly increases the efficiency of internal combustion engine ships which is likely to be highly attractive to fleet operators.
Today’s announcement is also a positive demonstration that CAPXX will be able to extract value from its IP Infringement settlement deal with Ioxus’s new owner, System Systematic Power Manufacturing LLC. The deal announced on 4 August 2022 provides CAP-XX exclusive rights to sell Ioxus modules in EMEA, APAC, Mexico, Central America, South America, Australia and New Zealand. Sales of these large high value products can make a significant impact on near-term revenues, helping CAP-XX in this breakthrough year to profitability, but also provides significant longer-term upside.
With value clearly being demonstrated through the growing product portfolio, and upside left in a number of areas such as litigation and new licensees, we continue to believe CAP-XX is significantly undervalued and iterate our Buy recommendation and 14p DCF based valuation.

https://twitter.com/surprised_trade/status/1592422259419119616

MARINE EDGE (maritime transportation ) made its first orders of CAP-XX's large, powerful, liquid-cooled supercapacitor modules for its PowerEdge system installations for cargo ships which reduce fuel consumption and minimise emissions.

A chronically undervalued healthcare opportunity


'...group first-half underlying pre-tax profit was largely unchanged at £2mn on 14 per cent higher revenue of £70mn, expect a strong showing in the second half as its Pioneer division benefits from rising NHS demand to reduce spiralling waiting lists. It’s already happening. Since the acquisition of Pioneer in the first half, the business has landed a £5mn one-year contract and four contract extensions worth £4.5mn. Chief executive Wendy Lawrence highlights an “increase in opportunities as the NHS refines its plans to meet commitments for no further increases in waiting list numbers.”

'...Moreover, as Totally wins more contracts then expect the earnings momentum to be maintained into the 2023/24 financial year, when Allenby predict pre-tax profit and EPS could rise to £7.9mn and 4.1p, respectively, based on revenue of £160mn.

Prospects for 116 per cent earnings growth over the two-year forecast period, coupled with the obvious need for the NHS to outsource more to cut waiting lists, were key bull points when I initiated coverage in the summer (‘Alpha Research: Profit from supporting NHS frontline services’, 28 July 2022). The investment case remains firmly intact, and I maintain my 70p target price. Buy.'

https://www.investorschronicle.co.uk/ideas/2022/11/14/a-chronically-undervalued-healthcare-opportunity/

very good summary Roth1, SQZ are and will still be proftable, WFT or not and with winter looming and a shortage of supply expected over the next few years, a cash generating profitable no debt business with a product everyone needs is a very decent investment, despite the odd price movement days...it's the irrational days that provide opportunity :-)

https://twitter.com/surprised_trade/status/1592166847792971780

a confident broker note

added to holding, sp pulled back from last weeks 440p & with todays' Equinor shut down & winter is coming.

Broker report...from six weeks ago...

'We believe that an investment in Kistos PLC (Kistos) is an opportunity to invest alongside a proven and highly incentivised management team, into an acquisition vehicle with an established North Sea gas production footprint of sufficient size to leverage the current commodity price cycle and use its stock currency to drive further consolidation in the basin. We see further upside from current levels (+110%) based on our assessment of intrinsic value. The value creation credentials of Kistos' management team go back to Rockrose Energy PLC (Rockrose) where they delivered a 37x cash-on-cash return for Rockrose investors who invested 50p at IPO in January 2016 and exited with the acquisition of Rockrose by Viaro Energy for £18.50 in August 2020. The Rockrose investment represented a very well-timed play on the oil price recovery which started in 2016 and is still ongoing. Having provided the seed investment to launch Kistos in 2020, the team has positioned the company to to play the upturn in the gas price cycle which started in 2021 and is currently reaping the benefits provided by the conjunction of structural forces in the industry and geopolitics. The acquisitions of quality gas assets starting with Tulip Oil (2021) and a 20% interest in the GLA (2022) from TotalEnergies have proved well timed for capitalising on higher gas prices and provide Kistos a reserves and resources footprint of sufficient size to become an even more attractive M&A partner.

With an EV/2P multiple of 18.3, Kistos trades close to the top of a peer group range (3.1-23.0). We believe this reflects the reserves conversion potential in the current portfolio as well as the value accretion potential of future M&A transaction under the current management team. The recent attempt to acquire Serica Energy Plc (Serica), one of the UK’s leading mid-tier independents and a UK North Sea gas producer with an extremely strong balance sheet, for cash and shares demonstrates Kistos' ambition to grow by leveraging its existing footprint and using its premium valuation as acquisition currency to play a driving role in the ongoing consolidation of the North Sea basin. We value Kistos at 874p per share, based on the prevalent commodity price scenario reflected in the gas and oil futures to date. Using mid-cycle commodity prices at a level lower than in the current overheated and volatile environment, we estimate a value of 525p per share, at a premium to the current share price.

we believe that the structural forces at play in the gas market as well as Kistos' aggressive M&A strategy provide material upside for investors coming in at this stage. '

https://www.reuters.com/business/energy/norways-equinor-owned-aasgard-b-oil-gas-platform-shut-after-fire-2022-11-14/

Gas production at Norwegian energy firm Equinor's (EQNR.OL) Aasgard B gas processing platform remains shut and partly evacuated following a fire in a transformer late on Sunday, a company spokesperson said on Monday.

Equinor is now working on getting an overview of the incident and starting the process to restart safe operations, the spokesperson said.

"I have no projection for how long this might take," he added.

Output at the field has been cut by 19.8 million cubic metres, Aasgard's pipeline operator Gassco said in a regulatory filing.

As a precautionary measure, Equinor evacuated 65 of the total 118 people working at Aasgard B, located some 200 km (124.27 miles) offshore in the Norwegian Sea, to nearby installations Aasgard A and Heidrun, Equinor said.

OSLO, Nov 14 (Reuters) - Gas production at Norwegian energy firm Equinor's (EQNR.OL) Aasgard B gas processing platform remains shut and partly evacuated following a fire in a transformer late on Sunday, a company spokesperson said on Monday.

Equinor is now working on getting an overview of the incident and starting the process to restart safe operations, the spokesperson said.

"I have no projection for how long this might take," he added.

Output at the field has been cut by 19.8 million cubic metres

Norway is still expected on Monday to deliver 304 million cubic metres of gas via pipelines to Britain and the European Union, however, supplies halted from now.

https://www.reuters.com/business/energy/norways-equinor-owned-aasgard-b-oil-gas-platform-shut-after-fire-2022-11-14/

'...Demand for its services remains strong and will continue to rise as the Group approaches the critical winter months. The Board expects to meet full year market consensus leading to a more H2 weighted year than has been typical in the past. Still grossly undervalued given the low risk profile and strong cash generation and ungeared balance sheet.

In the first half, the group delivered services to around 1.25m people and was awarded extensions to 15 existing urgent care contracts worth c.£37m. Energy Fitness Professionals was awarded a five-year contract extension for the management of gyms across 34 sites for the Royal Mail and Pioneer was awarded one new contract and four extensions in aggregate worth £9.5m

We expect the Group to generate strong growth in the second six months driven, in part, by the rising demand for Pioneer’s services which will be much needed by the NHS in reducing waiting lists, which in September topped 7.1m.

Consequently we leave forecasts unchanged highlighting the undervaluation of this Company given its strong growth, cash generation and solid, ungeared balance sheet. Fair value remains at 75p. '

https://twitter.com/surprised_trade/status/1592099669085401088

Financial highlights

· Group turnover up 14.1% to £70.3 million

· Gross profit up 2.6% to £11.9 million

· Increase in EBITDA profit to £3.4 million

· Profit before tax of £1.0 million

· Cash position of £7.4 million at 30 September 2022 (31 March 2022: £15.3 million) reflecting the impact of changes in our working capital model and accelerated growth

Pioneer's working capital model is different to the rest of the Group and income is not received as quickly as in other parts of the business, our cash position during the initial period of reporting has been disproportionately impacted, and in particular, over recent months as growth increased beyond management expectations. The position will normalise over coming quarters.

We will continue to invest in our businesses and in new opportunities that enhance earnings opportunities and increase shareholder value.

We are now seeing an increase in opportunities as the NHS refines its plans to meet commitments for no further increases in waiting list numbers across England, and the continuation of services throughout winter. We expect this part of the business to continue to grow as a result

We are seeing new opportunities being presented by commissioners for physiotherapy services and dermatology services and will update shareholders as these opportunities materialise.

we all have different views etc. tis what makes a market ...good luck Cornish1960 tough markets out there, particularly this last year .